Maat Pharma SA
F:4RD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Maat Pharma SA
F:4RD
|
FR |
|
NioCorp Developments Ltd
F:BR30
|
US |
|
E
|
Eneti Inc
F:SR4
|
MC |
|
D
|
DKSH Holding AG
XMUN:DS5
|
CH |
|
B
|
Banca Monte dei Paschi di Siena SpA
F:MPIN
|
IT |
|
A
|
adesso SE
XMUN:ADN1
|
DE |
|
Calnex Solutions PLC
F:CSO
|
UK |
Wall St Price Targets
4RD Price Targets Summary
Maat Pharma SA
According to Wall Street analysts, the average 1-year price target for 4RD is 17.33 EUR with a low forecast of 4.29 EUR and a high forecast of 25.28 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4RD's stock price target?
Price Target
17.33
EUR
According to Wall Street analysts, the average 1-year price target for 4RD is 17.33 EUR with a low forecast of 4.29 EUR and a high forecast of 25.28 EUR.
What is the Revenue forecast for Maat Pharma SA?
Projected CAGR
177%
The compound annual growth rate for Revenue over the next 3 years is 177%.
What is the Gross Profit forecast for Maat Pharma SA?
Projected CAGR
193%
The compound annual growth rate for Gross Profit over the next 2 years is 193%.
